ArticleThe Pan African medical journal2025
Thyroid-associated orbitopathy following COVID-19: a case report.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Autoimmune Thyroid Diseases After COVID-19 Infection: A Systematic Review of Clinical Manifestation and Outcomes.International journal of environmental research and public health · 2026Pooled it
- Review
- Post-COVID-19 Euthyroid Thyroid Eye Disease in a Young Woman: A Case Report of Optic Nerve Threat and Steroid-Responsive Course.Korean journal of ophthalmology : KJO · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies have shown a link between COVID-19 vaccination and the development of Graves' disease (GD) and Graves' orbitopathy (GO). However, to the best of our knowledge, this is only the second reported case of clinically overt GO following COVID-19 infection. Herein, we report a 48-year-old female patient who was initially treated in 2017 with radioactive iodine therapy for a toxic thyroid adenoma. In 2021, the patient was diagnosed with COVID-19. Ten days later, she developed bilateral, active, moderate-to-severe GO, accompanied by elevated thyrotropin receptor antibody (TRAb) levels. She was treated with intravenous methylprednisolone followed by oral prednisone and later underwent orbital decompression surgery, followed by strabismus surgery due to worsening diplopia. No complications occurred postoperatively, and her symptoms improved significantly. This case contributes to the literature by suggesting a potential association between COVID-19 infection and the onset of autoimmune diseases, including GO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.